Santen Pharmaceutical Statistics
Total Valuation
SNPHY has a market cap or net worth of 3.35 billion. The enterprise value is 2.80 billion.
| Market Cap | 3.35B |
| Enterprise Value | 2.80B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.34% |
| Shares Change (QoQ) | -1.90% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 329.77M |
Valuation Ratios
The trailing PE ratio is 19.18.
| PE Ratio | 19.18 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| PB Ratio | 1.86 |
| P/TBV Ratio | 2.58 |
| P/FCF Ratio | 11.41 |
| P/OCF Ratio | 9.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.16, with an EV/FCF ratio of 9.53.
| EV / Earnings | 16.01 |
| EV / Sales | 1.32 |
| EV / EBITDA | 6.16 |
| EV / EBIT | 8.55 |
| EV / FCF | 9.53 |
Financial Position
The company has a current ratio of 2.61
| Current Ratio | 2.61 |
| Quick Ratio | 1.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 43.93 |
Financial Efficiency
Return on equity (ROE) is 9.45% and return on invested capital (ROIC) is 11.02%.
| Return on Equity (ROE) | 9.45% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 11.02% |
| Return on Capital Employed (ROCE) | 16.02% |
| Revenue Per Employee | 512,893 |
| Profits Per Employee | 46,708 |
| Employee Count | 3,744 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.85% in the last 52 weeks. The beta is 0.20, so SNPHY's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +2.85% |
| 50-Day Moving Average | 9.52 |
| 200-Day Moving Average | 10.85 |
| Relative Strength Index (RSI) | 54.10 |
| Average Volume (20 Days) | 8,160 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNPHY had revenue of 1.92 billion and earned 174.88 million in profits. Earnings per share was 0.49.
| Revenue | 1.92B |
| Gross Profit | 1.10B |
| Operating Income | 325.80M |
| Pretax Income | 201.14M |
| Net Income | 174.88M |
| EBITDA | 440.99M |
| EBIT | 325.80M |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 495.17 million in cash and n/a in debt, giving a net cash position of 495.17 million.
| Cash & Cash Equivalents | 495.17M |
| Total Debt | n/a |
| Net Cash | 495.17M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.80B |
| Book Value Per Share | 5.29 |
| Working Capital | 805.30M |
Cash Flow
In the last 12 months, operating cash flow was 351.40 million and capital expenditures -57.54 million, giving a free cash flow of 293.86 million.
| Operating Cash Flow | 351.40M |
| Capital Expenditures | -57.54M |
| Free Cash Flow | 293.86M |
| FCF Per Share | n/a |
Margins
Gross margin is 57.17%, with operating and profit margins of 16.97% and 9.11%.
| Gross Margin | 57.17% |
| Operating Margin | 16.97% |
| Pretax Margin | 10.47% |
| Profit Margin | 9.11% |
| EBITDA Margin | 22.96% |
| EBIT Margin | 16.97% |
| FCF Margin | 15.30% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.44%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 2.44% |
| Dividend Growth (YoY) | 11.90% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.13% |
| Buyback Yield | 4.34% |
| Shareholder Yield | 6.78% |
| Earnings Yield | 5.21% |
| FCF Yield | 8.76% |
Stock Splits
The last stock split was on April 2, 2015. It was a forward split with a ratio of 2.5.
| Last Split Date | Apr 2, 2015 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
SNPHY has an Altman Z-Score of 5.39.
| Altman Z-Score | 5.39 |
| Piotroski F-Score | n/a |